ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ARS PHARMACEUTICALS, INC.

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY)
Listen to this Section


$6.27
-0.1750 ( -2.72% ) 2.7M

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Market Data


Open $6.27
Previous Close $6.44
Volume 2.7M
Market Cap $639.51M
Day Range $6.17 - $6.94
52 Week Range $6.17 - $18.63
Shares Outstanding 99.30M
Change % -2.72%
Net Change ▼ -0.1750
Insider Ownership -0.24%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2022
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -1,273,987.00

Date Type Amount Purchased Purchaser
2024-07-18 Sale -50000.00 Tanimoto Sarina
2024-07-18 Sale -50000.00 Lowenthal Richard E
2024-07-11 Sale -50000.00 Lowenthal Richard E
2024-07-11 Sale -50000.00 Tanimoto Sarina
2024-06-24 Sale -40000.00 Islam Saqib
2024-06-24 Sale -40000.00 SAUNDERS BRENT L
2024-06-24 Sale -40000.00 Thompson Peter A.
2024-06-24 Sale -40000.00 Dadoo Rajeev
2024-06-24 Sale -40000.00 Shah Pratik
2024-06-24 Sale -40000.00 RA CAPITAL MANAGEMENT, L.P.

SEC Filings


Form Type Description Pages Date
4 Insider transactions 2 Jul 01, 2025

Latest News